Latvia Beta Blocking Medicine Sales is set to reach $8.64 Million by 2026 from $8.36 Million, is expected to fall by 0.8% per year. Since 2017, the market was up 2.4% year on year close to $2,480 Million. Italy, Canada and Australia respectively ranked numbers 2, 3 and 4 in this ranking.